Novozymes A S DKK 2.0
13F holders, Q1 2026 (March 31)3holders
2new positions
2sold out
$59.02avg. 13F price*
At the end of Q1 2026, 3 institutions reported holding Novozymes A S DKK 2.0 in their 13F filings, unchanged from Q4 2025. 2 opened new positions and 2 sold out. The largest holders were Delaney Dennis R ($575K), Somerville Kurt F ($221K) and Elefante Mark B ($201K).
- Company
- Novozymes A S DKK 2.0
- CUSIP
- B798FW902
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $776K |
| Exits | 2 | $417K |
All 13F filers, Q4 2025 → Q1 2026: 13,150 shares bought and 19,271 shares sold, net −6,121 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Delaney Dennis R | 0.20% | New | 9,750 | $575K |
| Somerville Kurt F | 0.06% | Reduce -77.3% | 3,740 | $221K |
| Elefante Mark B | 0.11% | New | 3,400 | $201K |
"% of holder's portfolio" is NOVOZYMES A S DKK 2.0's weight in each manager's 13F, not the share of Novozymes A S DKK 2.0 the manager owns.